- Home
- TMDX vs NJR Comparison
TMDX vs NJR Comparison
Compare TMDX & NJR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TMDX | NJR |
|---|---|---|
| Founded | 1998 | 1922 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Oil/Gas Transmission |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.5B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | TMDX | NJR |
|---|---|---|
| Price | $129.52 | $53.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 6 |
| Target Price | ★ $144.25 | $52.17 |
| AVG Volume (30 Days) | ★ 753.2K | 621.0K |
| Earning Date | 02-24-2026 | 02-02-2026 |
| Dividend Yield | N/A | ★ 3.60% |
| EPS Growth | ★ 170.70 | N/A |
| EPS | 2.54 | ★ 3.23 |
| Revenue | $566,354,000.00 | ★ $2,152,905,000.00 |
| Revenue This Year | $38.73 | $11.52 |
| Revenue Next Year | $20.55 | $5.37 |
| P/E Ratio | $52.56 | ★ $16.35 |
| Revenue Growth | ★ 41.20 | 18.44 |
| 52 Week Low | $62.07 | $43.46 |
| 52 Week High | $156.00 | $53.65 |
Technical Indicators
Market Signals| Indicator | TMDX | NJR |
|---|---|---|
| Relative Strength Index (RSI) | 43.77 | 79.19 |
| Support Level | $127.00 | $51.43 |
| Resistance Level | $140.72 | $53.65 |
| Average True Range (ATR) | 6.68 | 1.03 |
| MACD | -0.70 | 0.31 |
| Stochastic Oscillator | 13.23 | 95.65 |
Price Performance
Historical ComparisonAbout TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
About NJR NewJersey Resources Corporation
New Jersey Resources is an energy services holding company with regulated and nonregulated operations. Its regulated utility, New Jersey Natural Gas, delivers natural gas to nearly 600,000 customers in the state. NJR's nonregulated businesses include investments in commercial solar projects and several large midstream natural gas projects.